nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—ACHE—Biogenic Amine Synthesis—DBH—Parkinson's disease	0.0646	0.0646	CbGpPWpGaD
Pralidoxime—ACHE—Biogenic Amine Synthesis—DDC—Parkinson's disease	0.0474	0.0474	CbGpPWpGaD
Pralidoxime—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Parkinson's disease	0.0437	0.0437	CbGpPWpGaD
Pralidoxime—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Parkinson's disease	0.039	0.039	CbGpPWpGaD
Pralidoxime—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—Parkinson's disease	0.0372	0.0372	CbGpPWpGaD
Pralidoxime—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—Parkinson's disease	0.0369	0.0369	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—DBH—Parkinson's disease	0.0352	0.0352	CbGpPWpGaD
Pralidoxime—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—Parkinson's disease	0.0332	0.0332	CbGpPWpGaD
Pralidoxime—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—Parkinson's disease	0.0329	0.0329	CbGpPWpGaD
Pralidoxime—ACHE—Biogenic Amine Synthesis—TH—Parkinson's disease	0.0264	0.0264	CbGpPWpGaD
Pralidoxime—ACHE—Biogenic Amine Synthesis—COMT—Parkinson's disease	0.0225	0.0225	CbGpPWpGaD
Pralidoxime—ACHE—Biogenic Amine Synthesis—MAOA—Parkinson's disease	0.0223	0.0223	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—ADORA2A—Parkinson's disease	0.0193	0.0193	CbGpPWpGaD
Pralidoxime—ACHE—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.0175	0.0175	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—SLC6A3—Parkinson's disease	0.0144	0.0144	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—TH—Parkinson's disease	0.0144	0.0144	CbGpPWpGaD
Pralidoxime—ACHE—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.0132	0.0132	CbGpPWpGaD
Pralidoxime—ACHE—Synthesis, secretion, and deacylation of Ghrelin—INS—Parkinson's disease	0.0131	0.0131	CbGpPWpGaD
Pralidoxime—ACHE—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.0123	0.0123	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—ATP6AP2—Parkinson's disease	0.0122	0.0122	CbGpPWpGaD
Pralidoxime—BCHE—Synthesis, secretion, and deacylation of Ghrelin—INS—Parkinson's disease	0.0117	0.0117	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—ATP6AP2—Parkinson's disease	0.0109	0.0109	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—HCN3—Parkinson's disease	0.0109	0.0109	CbGpPWpGaD
Pralidoxime—ACHE—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00998	0.00998	CbGpPWpGaD
Pralidoxime—ACHE—Glycerophospholipid biosynthesis—PLA2G6—Parkinson's disease	0.00979	0.00979	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—HCN3—Parkinson's disease	0.00968	0.00968	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00913	0.00913	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—TH—Parkinson's disease	0.00884	0.00884	CbGpPWpGaD
Pralidoxime—BCHE—Glycerophospholipid biosynthesis—PLA2G6—Parkinson's disease	0.00873	0.00873	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00814	0.00814	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00788	0.00788	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00703	0.00703	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—KCNJ4—Parkinson's disease	0.00699	0.00699	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PLA2G6—Parkinson's disease	0.00683	0.00683	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—KCNJ4—Parkinson's disease	0.00624	0.00624	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00616	0.00616	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PLA2G6—Parkinson's disease	0.00609	0.00609	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—DLG1—Parkinson's disease	0.00604	0.00604	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—IL1B—Parkinson's disease	0.00588	0.00588	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.0057	0.0057	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.0055	0.0055	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—DLG1—Parkinson's disease	0.00538	0.00538	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00524	0.00524	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00508	0.00508	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—INS—Parkinson's disease	0.00483	0.00483	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00473	0.00473	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIK1—Parkinson's disease	0.00472	0.00472	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00468	0.00468	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00453	0.00453	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—TNF—Parkinson's disease	0.00427	0.00427	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIK1—Parkinson's disease	0.00421	0.00421	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00402	0.00402	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIK2—Parkinson's disease	0.00402	0.00402	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—SLC18A2—Parkinson's disease	0.00389	0.00389	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00368	0.00368	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—INS—Parkinson's disease	0.00361	0.00361	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00358	0.00358	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIK2—Parkinson's disease	0.00358	0.00358	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00352	0.00352	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—SLC18A2—Parkinson's disease	0.00347	0.00347	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00346	0.00346	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—HSPA9—Parkinson's disease	0.00342	0.00342	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00338	0.00338	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00333	0.00333	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MAPK8—Parkinson's disease	0.00331	0.00331	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00329	0.00329	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—INS—Parkinson's disease	0.00322	0.00322	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00314	0.00314	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00308	0.00308	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CHRNA4—Parkinson's disease	0.00308	0.00308	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—HSPA9—Parkinson's disease	0.00305	0.00305	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00301	0.00301	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00297	0.00297	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00286	0.00286	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00283	0.00283	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—HSPA8—Parkinson's disease	0.00282	0.00282	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00281	0.00281	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00281	0.00281	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00277	0.00277	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CHRNA4—Parkinson's disease	0.00275	0.00275	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—DLG4—Parkinson's disease	0.00265	0.00265	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIN2B—Parkinson's disease	0.00259	0.00259	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—SLC6A3—Parkinson's disease	0.00255	0.00255	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00253	0.00253	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—HSPA8—Parkinson's disease	0.00252	0.00252	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00251	0.00251	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.0025	0.0025	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPL6—Parkinson's disease	0.00243	0.00243	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—DLG4—Parkinson's disease	0.00236	0.00236	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIN2B—Parkinson's disease	0.00231	0.00231	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.00231	0.00231	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—SLC6A3—Parkinson's disease	0.00228	0.00228	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.0022	0.0022	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPL6—Parkinson's disease	0.00217	0.00217	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—COMT—Parkinson's disease	0.00217	0.00217	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—MAOA—Parkinson's disease	0.00215	0.00215	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—IL6—Parkinson's disease	0.00211	0.00211	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—DCTN1—Parkinson's disease	0.00211	0.00211	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MCCC1—Parkinson's disease	0.00207	0.00207	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ND3—Parkinson's disease	0.00207	0.00207	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.00206	0.00206	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00196	0.00196	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TALDO1—Parkinson's disease	0.00195	0.00195	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—OMD—Parkinson's disease	0.00195	0.00195	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—COMT—Parkinson's disease	0.00193	0.00193	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—MAOA—Parkinson's disease	0.00192	0.00192	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—DCTN1—Parkinson's disease	0.00188	0.00188	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MCCC1—Parkinson's disease	0.00185	0.00185	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ND3—Parkinson's disease	0.00185	0.00185	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NDUFB11—Parkinson's disease	0.00185	0.00185	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPL14—Parkinson's disease	0.00184	0.00184	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPL23A—Parkinson's disease	0.00184	0.00184	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GCH1—Parkinson's disease	0.00176	0.00176	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TALDO1—Parkinson's disease	0.00174	0.00174	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—OMD—Parkinson's disease	0.00174	0.00174	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPS8—Parkinson's disease	0.00172	0.00172	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NDUFB11—Parkinson's disease	0.00165	0.00165	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPL14—Parkinson's disease	0.00165	0.00165	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPL23A—Parkinson's disease	0.00165	0.00165	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00159	0.00159	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GCH1—Parkinson's disease	0.00157	0.00157	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GBA—Parkinson's disease	0.00157	0.00157	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—FBP1—Parkinson's disease	0.00157	0.00157	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—DBH—Parkinson's disease	0.00157	0.00157	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPS8—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00142	0.00142	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.00141	0.00141	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GBA—Parkinson's disease	0.0014	0.0014	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—FBP1—Parkinson's disease	0.0014	0.0014	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—DBH—Parkinson's disease	0.0014	0.0014	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.00129	0.00129	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—DDC—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA4—Parkinson's disease	0.00109	0.00109	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00107	0.00107	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—DDC—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGF2—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLA2G6—Parkinson's disease	0.000979	0.000979	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA4—Parkinson's disease	0.00097	0.00097	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MAOB—Parkinson's disease	0.00097	0.00097	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000958	0.000958	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000923	0.000923	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGF2—Parkinson's disease	0.000915	0.000915	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLA2G6—Parkinson's disease	0.000874	0.000874	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MAOB—Parkinson's disease	0.000865	0.000865	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000823	0.000823	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2D6—Parkinson's disease	0.000721	0.000721	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CTGF—Parkinson's disease	0.000707	0.000707	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—INS—Parkinson's disease	0.000681	0.000681	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2E1—Parkinson's disease	0.000659	0.000659	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NQO1—Parkinson's disease	0.000652	0.000652	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2D6—Parkinson's disease	0.000643	0.000643	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TH—Parkinson's disease	0.000642	0.000642	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CTGF—Parkinson's disease	0.000631	0.000631	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYCS—Parkinson's disease	0.000617	0.000617	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—INS—Parkinson's disease	0.000608	0.000608	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2E1—Parkinson's disease	0.000588	0.000588	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NQO1—Parkinson's disease	0.000581	0.000581	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TH—Parkinson's disease	0.000573	0.000573	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYCS—Parkinson's disease	0.00055	0.00055	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—COMT—Parkinson's disease	0.000546	0.000546	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTP1—Parkinson's disease	0.000544	0.000544	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MAOA—Parkinson's disease	0.000542	0.000542	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMOX1—Parkinson's disease	0.000536	0.000536	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCB1—Parkinson's disease	0.000515	0.000515	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTM1—Parkinson's disease	0.000499	0.000499	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—COMT—Parkinson's disease	0.000487	0.000487	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTP1—Parkinson's disease	0.000485	0.000485	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MAOA—Parkinson's disease	0.000484	0.000484	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GPX1—Parkinson's disease	0.000478	0.000478	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMOX1—Parkinson's disease	0.000478	0.000478	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCB1—Parkinson's disease	0.000459	0.000459	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTM1—Parkinson's disease	0.000446	0.000446	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTHFR—Parkinson's disease	0.000441	0.000441	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GPX1—Parkinson's disease	0.000427	0.000427	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOE—Parkinson's disease	0.000411	0.000411	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTHFR—Parkinson's disease	0.000394	0.000394	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOE—Parkinson's disease	0.000367	0.000367	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—INS—Parkinson's disease	0.000351	0.000351	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—INS—Parkinson's disease	0.000313	0.000313	CbGpPWpGaD
